Spots Global Cancer Trial Database for Everolimus After (Chemo)Embolization for Liver Metastases From Digestive Endocrine Tumors
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Everolimus After (Chemo)Embolization for Liver Metastases From Digestive Endocrine Tumors
Official Title: Everolimus as Treatment After Embolization or Chemoembolization for Liver Metastases From Digestive Endocrine Tumors
Study ID: NCT01678664
Study Description
Brief Summary: Determine wether 24 months treatment with everolimus prolongs progression free survival rate (based on a central assessment) after embolisation ou chemoembolisation for liver metastases. * H0 a 24 months progression free survival rate less than 35% is unacceptable * H1 a 24 months progression free survival rate greater than 35% would show that everolimus treatment is beneficial, the expected 24 months progression free survival rate being 50%
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
CHU - Hôtel Dieu, Angers, , France
Hôpital Avicenne, Bobigny, , France
Hôpital Saint André, Bordeaux, , France
Hôpital Côte de Nacre, Caen, , France
CHU - Estaing, Clermont Ferrand, , France
Hôpital Beaujon, Clichy, , France
Centre GF Leclerc, Dijon, , France
CHU - Hôpital François Mitterand, Dijon, , France
Hôpital Edouard Herriot, Lyon, , France
CHU La Timone, Marseille, , France
CHR, Orléans, , France
CHU Cochin, Paris, , France
Hôpital Européen Georges Pompidou, Paris, , France
Hôpital Robert Debré, Reims, , France
CHU, Rouen, , France
Hôpital Rangueil, Toulouse, , France
Hôpital Trousseau, Tours, , France
Institut Gustave Roussy, Villejuif, , France
Contact Details
Name: Thomas WALTER, PhD
Affiliation: Hôpital Edouard Herriot - Lyon
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
